Gentamicin for Treatment of Neonatal Sepsis—A Landscape of Formulation, Packaging, and Delivery Alternatives

Neonatal infections are a major cause of newborn mortality in low-resource settings. In view of the World Health Organization’s new 2015 guidelines for outpatient treatment of neonatal sepsis when referral is not feasible, PATH reviewed a range of drug formulation, packaging, and delivery technologies that might be applied to gentamicin delivery for infants at primary care to improve safety, ease of delivery, and potentially expand access.

Publication date: October 2015

Gentamicin for Treatment of Neonatal Sepsis—A Landscape of Formulation, Packaging, and Delivery Alternatives

1.6 MB PDF

Hard copies are not available.

View Resource